Insider Transactions in Q2 2025 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2025
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
15,192
-5.14%
|
$15,192
$1.72 P/Share
|
|
Jun 03
2025
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
726
-1.03%
|
$726
$1.72 P/Share
|
|
Jun 03
2025
|
Amy Parison SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
446
-2.48%
|
$446
$1.72 P/Share
|